Search Within

Fred Shapiro

Formats
  1. Meeting Abstract (20)
  2. Journal Article (16)
  3. Conference Paper (1)
Groups
  1. Cell Biology Program Faculty (25)
  2. Sloan Kettering Institute Faculty (25)
  3. Department of Medicine (19)
  4. Solid Tumor Oncology Division (16)
  5. Hematologic Malignancies, Division of (12)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)

More Groups

People
  1. Malcolm Moore (25)
  2. David Fennelly (12)
  3. Lilian Reich (12)
  4. David Spriggs (11)
  5. Larry Norton (11)
  6. Jeffrey Schneider (10)

More People

Years
  1. 1998 (2)
  2. 1997 (7)
  3. 1996 (7)
  4. 1995 (8)
  5. 1994 (9)
  6. 1993 (4)
Publications
  1. Blood (15)
  2. Gynecologic Oncology (5)
  3. Experimental Hematology (3)
  4. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  5. Journal of Clinical Oncology (2)
  6. Seminars in Oncology (2)

More Publications

Publishers
  1. American Society of Hematology (15)
  2. Elsevier Inc. (9)
  3. American Association for Cancer Research (4)
  4. Elsevier Science, Inc. (3)
  5. American Society of Clinical Oncology (2)
  6. John Wiley & Sons, Inc. (1)

More Publishers

Results (37)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Ex vivo stem and progenitor cell expansion strategies
    Meeting Abstract

    Moore, M. A. S.; Pettengell, R.; Engelhardt, M.; Frey, B.; Shapiro, F.
    Experimental Hematology (1996)

    Fulltext@MSK | Save
  • Human bone marrow microvascular endothelial cells induce expansion of CD34(+) progenitors by direct cellular contact
    Meeting Abstract

    Rafii, S.; Mohle, R.; Shapiro, F.; Frey, B.; Nachman, R. L.; Moore, M. A. S.
    Experimental Hematology (1996)

    Fulltext@MSK | Save
  • Telomere length shortening and recovery following high-dose chemotherapy with autologous peripheral stem cell rescue
    Meeting Abstract

    Shapiro, F.; Engelhardt, M.; Ngok, D.; Han, W.; Moore, M. A. S.
    Blood (1996)

    Fulltext@MSK | Save
  • The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood
    Journal Article

    Shapiro, F.; Pytowski, B.; Rafii, S.; Witte, L.; Hicklin, D. J.; Yao, T. J.; Moore, M. A. S.
    Journal of Hematotherapy and Stem Cell Research (1996)

    Fulltext@MSK | Save
  • The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer
    Journal Article

    Gogas, H.; Shapiro, F.; Aghajanian, C.; Fennelly, D.; Almadrones, L.; Hoskins, W. J.; Spriggs, D. R.
    Gynecologic Oncology (1996)

    Fulltext@MSK | Save
  • Treatment of resistant gestational choriocarcinoma with taxol: A report of two cases
    Journal Article

    Jones, W. B.; Schneider, J.; Shapiro, F.; Lewis, J. L. Jr
    Gynecologic Oncology (1996)

    Fulltext@MSK | Save
  • Phase I trial of escalating dose taxol administered weekly in patients with persistent ovarian cancer
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Aghajanian, C.; Norton, L.; Spriggs, D.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save
  • Flk-2 ligand is superior to c-kit ligand at maintaining long-term hematopoietic progenitors in liquid culture
    Meeting Abstract

    Shapiro, F.; Pytowski, B.; Hicklin, D. J.; Witte, L.; Moore, M. A. S.
    Proceedings of the American Association for Cancer Research Annual Meeting (1995)

    Fulltext@MSK | Save
  • Phase I study of Taxol administered weekly in patients with persistent ovarian cancer
    Meeting Abstract

    Fennelly, D.; Shapiro, F.; Spriggs, D.; Aghajanian, C.; Francis, P.; Lewis, J. L.; Jones, W.; Curtin, J.; Barakat, R.; Hoskins, W.
    European Journal of Cancer (1995)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save